Testosterone Replacement Therapy (TRT)

What Is Testosterone Replacement Therapy?

Testosterone replacement therapy (TRT) is a medically supervised treatment that restores testosterone levels in men diagnosed with hypogonadism -- a clinical condition in which the body fails to produce adequate amounts of testosterone. Testosterone is the primary male sex hormone, responsible for regulating libido, bone density, fat distribution, muscle mass and strength, red blood cell production, and sperm production. When levels fall below the clinical threshold, virtually every system in the body is affected.

In healthy men, testosterone production begins declining at approximately 1% per year after the age of 30, according to longitudinal data published in the Journal of Clinical Endocrinology & Metabolism. By age 45, roughly 40% of men have total testosterone levels below 300 ng/dL -- the threshold established by the American Urological Association (AUA) as the diagnostic cutoff for testosterone deficiency. By age 70, that figure rises to more than 50%. This natural decline, sometimes called "andropause" or "late-onset hypogonadism," is distinct from pathological hypogonadism but can produce the same debilitating symptoms.

Hypogonadism is classified into two categories. Primary hypogonadism (hypergonadotropic) originates in the testes themselves -- caused by conditions such as Klinefelter syndrome, undescended testes, testicular injury, or prior chemotherapy. In these cases, LH and FSH levels are elevated because the pituitary gland is signaling the testes to produce more testosterone, but the testes cannot respond. Secondary hypogonadism (hypogonadotropic) originates in the hypothalamus or pituitary gland. Causes include pituitary tumors, obesity, opioid use, chronic illness, or idiopathic dysfunction. Here, LH and FSH are low or inappropriately normal because the brain is not sending adequate signals. The distinction matters because it determines treatment approach: primary hypogonadism generally requires exogenous testosterone, while secondary hypogonadism may respond to clomiphene citrate or other agents that stimulate the body's own production.

Signs and Symptoms of Low Testosterone

Low testosterone (hypogonadism) produces a wide constellation of symptoms that affect sexual, physical, cognitive, and metabolic health. Many men dismiss these symptoms as normal aging, stress, or poor sleep -- which delays diagnosis by an average of 4-5 years according to endocrine practice surveys. Recognizing these symptoms is the first step toward getting appropriate testing and treatment.

Sexual Symptoms

• Decreased libido -- reduced interest in sexual activity, often the earliest and most noticeable symptom
• Erectile dysfunction -- difficulty achieving or maintaining erections, particularly spontaneous morning erections
• Reduced morning erections -- healthy men typically experience 3-5 nocturnal erections; a decline suggests hormonal insufficiency
• Decreased ejaculate volume and reduced orgasm intensity

Physical Symptoms

• Persistent fatigue -- overwhelming tiredness that does not improve with adequate sleep
• Loss of muscle mass and strength -- difficulty building or maintaining muscle despite regular exercise
• Increased body fat -- especially visceral abdominal fat, sometimes with gynecomastia (breast tissue development)
• Decreased bone mineral density -- increased fracture risk, particularly at the hip and spine
• Hair loss -- thinning of body and facial hair (distinct from androgenetic alopecia)

Cognitive and Emotional Symptoms

• Brain fog -- difficulty with concentration, memory, and mental clarity
• Depression and low mood -- studies show men with low T have a 2-3x higher rate of depressive symptoms
• Irritability and mood swings -- disproportionate emotional reactions
• Poor motivation -- loss of drive and ambition, reduced competitive instinct
• Sleep disturbances -- insomnia or non-restorative sleep despite adequate duration

Metabolic Symptoms

• Insulin resistance -- impaired glucose metabolism that precedes type 2 diabetes
• Metabolic syndrome -- the cluster of elevated blood pressure, high blood sugar, excess waist circumference, and abnormal lipid levels
• Elevated cholesterol -- particularly increased LDL and triglycerides with decreased HDL

Diagnosis: Do You Qualify for TRT?

A TRT diagnosis requires both clinical symptoms and confirmed low testosterone levels through laboratory testing. Neither symptoms alone nor a single low lab result is sufficient for diagnosis, according to both the American Urological Association (AUA) and the Endocrine Society clinical practice guidelines.

The AUA defines testosterone deficiency as a total testosterone level below 300 ng/dL (10.4 nmol/L), measured on at least two separate morning blood draws. Morning testing is critical because testosterone follows a circadian rhythm, peaking between 7:00 AM and 10:00 AM and declining by 20-25% by late afternoon. A single afternoon blood draw could produce a falsely low reading. The two-test requirement accounts for day-to-day biological variation, which can be as high as 15-20% between samples.

Beyond total testosterone, a comprehensive diagnostic workup includes several additional labs that provide a fuller picture of your hormonal health:

• Free testosterone -- the unbound, bioavailable fraction (typically 2-3% of total T); may be low even when total T is borderline normal, especially in older men or those with elevated SHBG
• Sex hormone-binding globulin (SHBG) -- the protein that binds testosterone; elevated SHBG (common with aging, liver disease, or hyperthyroidism) reduces free T availability
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) -- distinguish primary from secondary hypogonadism
• Prolactin -- elevated levels may indicate a pituitary adenoma causing secondary hypogonadism
• Complete blood count (CBC) -- baseline hematocrit and hemoglobin before starting TRT
• Comprehensive metabolic panel (CMP) -- liver and kidney function assessment
• Lipid panel -- baseline cardiovascular risk markers
• Estradiol (E2) -- baseline estrogen level, important for monitoring aromatization on TRT
• PSA (prostate-specific antigen) -- baseline prostate health marker for men over 40

Testosterone Delivery Methods Compared

There is no single "best" testosterone delivery method -- the optimal choice depends on your lifestyle, budget, insurance coverage, comfort with injections, fertility goals, and how your body responds to treatment. Below is a detailed comparison of the four primary TRT delivery methods available in 2026.

Intramuscular Injections (Testosterone Cypionate and Enanthate)

Injectable testosterone remains the most widely prescribed and cost-effective form of TRT. Testosterone cypionate, the most common formulation in the United States, has an elimination half-life of approximately 8 days and is dissolved in cottonseed oil or grapeseed oil. Testosterone enanthate has a slightly shorter half-life of 5-7 days and is typically dissolved in sesame oil. Both are administered via intramuscular injection into the gluteal, deltoid, or vastus lateralis muscle, or subcutaneously into abdominal fat.

The typical starting dose is 100-200 mg per week, or 200 mg every two weeks. Injections produce a pharmacokinetic curve with a peak approximately 24-48 hours post-injection, followed by a gradual decline. This creates the characteristic "peaks and troughs" pattern -- energy and mood may feel elevated in the first 2-3 days, then gradually diminish before the next injection. Many patients and clinicians prefer splitting doses (e.g., 50-80 mg every 3.5 days) to produce more stable serum levels and reduce estrogen conversion.

Injectable testosterone is by far the least expensive option, with generic testosterone cypionate costing $30-120 for a 10 mL vial (approximately a 10-week supply at standard doses). Insurance coverage is common, bringing out-of-pocket costs to $10-30 per fill. The trade-off is the need for self-injection, which requires learning proper technique, rotating injection sites, and maintaining sterile supplies.

Topical Gels (AndroGel, Testim, Fortesta)

Testosterone gels provide steady-state hormone levels through daily transdermal absorption. Brand-name options include AndroGel (1% and 1.62% concentrations), Testim (1%), and Fortesta (2%). The gel is applied each morning to clean, dry skin on the shoulders, upper arms, or inner thighs, and absorbs within 2-3 hours. Patients must avoid swimming, showering, or skin-to-skin contact at the application site during that window.

The primary advantage of gels is convenience and stable pharmacokinetics -- there are no injection-related peaks and troughs, which some patients prefer. However, gels carry a significant transference risk: testosterone can be transferred to partners, children, or pets through skin contact, potentially causing virilization in women and children (a concern serious enough that the FDA requires a black-box warning). Absorption rates also vary considerably between individuals -- some men absorb only 10-15% of the applied dose, requiring higher concentrations or supplemental injections to reach therapeutic levels.

Cost is the main disadvantage. Brand-name gels run $400-1,000 per month without insurance. Compounded testosterone cream from specialty pharmacies costs $50-150 per month and offers identical efficacy. Insurance coverage varies widely; many plans require step therapy (trying generics or injections first).

Subcutaneous Pellets (Testopel)

Testopel pellets are small, crystalline testosterone implants (each about the size of a grain of rice) surgically inserted beneath the skin of the upper buttock or hip area during a brief in-office procedure under local anesthesia. Typically 6-12 pellets are implanted at once, providing a slow, steady release of testosterone over 3-6 months. This is the closest available approximation to the body's natural continuous hormone production.

Pellets eliminate all daily or weekly maintenance -- there are no injections, no gels, and no risk of transference. However, once implanted, the dose cannot be easily adjusted if levels are too high or if side effects develop. Pellet extrusion (where a pellet works its way to the skin surface) occurs in approximately 5-10% of insertions and requires a minor repeat procedure. Each insertion costs $500-1,500 out of pocket, with insurance coverage varying significantly. Averaged monthly, the cost is roughly $100-375.

Nasal Gel (Natesto)

Natesto is a newer testosterone formulation applied as a gel inside the nostrils three times daily (morning, afternoon, and evening). Each actuation delivers 5.5 mg of testosterone. Natesto's distinguishing clinical advantage is its reduced suppression of the hypothalamic-pituitary-gonadal (HPG) axis compared to other TRT methods. Because the short-acting nasal delivery produces brief testosterone spikes rather than sustained elevation, LH and FSH suppression is less pronounced, which means spermatogenesis may be partially preserved.

This makes Natesto a consideration for men who want testosterone therapy but are concerned about fertility. However, it is less effective at raising total testosterone into the upper-normal range, and the three-times-daily dosing schedule is inconvenient for many patients. Nasal irritation, rhinorrhea, and altered sense of smell are common side effects. Cost is $200-500 per month, and insurance coverage is rare.

Delivery Method Comparison Table

Dosing Protocols

Testosterone dosing is not one-size-fits-all. The goal is to restore your serum testosterone to the mid-normal physiological range -- typically a trough level of 400-700 ng/dL -- while minimizing side effects. Your prescribing physician will individualize your dose based on your baseline labs, symptoms, body weight, and response to treatment.

For injectable testosterone cypionate, the most common starting protocol is 100 mg per week administered intramuscularly or subcutaneously. Some clinicians start at 150-200 mg every two weeks, though this wider interval tends to produce more pronounced peaks and troughs that patients often feel as mood and energy fluctuations. At your first follow-up (6-8 weeks after starting), blood work will reveal whether your dose needs adjustment. If your trough level is below 400 ng/dL and symptoms persist, the dose is increased by 20-40 mg. If your trough exceeds 700 ng/dL or hematocrit rises above 50%, the dose is reduced.

Split dosing has become increasingly popular among TRT clinicians. Instead of one weekly injection, the dose is divided into two administrations -- for example, 50 mg every 3.5 days instead of 100 mg once weekly. This approach produces flatter serum levels, reduces the peak-to-trough ratio by approximately 40%, and lowers estrogen conversion (aromatization) because the body is not processing a large bolus of testosterone at once. Many patients report fewer mood swings, more consistent energy, less water retention, and reduced acne on split protocols.

For gels, dosing is typically adjusted by the amount applied daily: AndroGel 1.62% starts at 40.5 mg daily (two pump actuations), adjustable to 20.25-81 mg based on lab results. Pellet dosing depends on the number of pellets implanted (usually 6-12 x 75 mg each = 450-900 mg total), calibrated to your body mass and metabolic rate.

Monitoring and Lab Work

Ongoing monitoring is one of the most critical -- and most often neglected -- aspects of successful TRT. Testosterone therapy is not a "set it and forget it" treatment. Regular blood work ensures your levels remain in the therapeutic range, detects side effects before they become clinically significant, and allows your physician to optimize your protocol over time.

Monitoring Schedule

• Baseline (before starting TRT) -- Complete panel: Total T, Free T, SHBG, LH, FSH, Estradiol, Prolactin, CBC, CMP, Lipid Panel, PSA (men over 40), and thyroid panel (TSH, Free T4)
• 6-8 weeks after starting -- First follow-up: Total T (trough), Free T, Estradiol (E2), CBC with hematocrit, CMP. This is the most important lab draw because it determines whether your starting dose is appropriate.
• Every 3-6 months for the first year -- Total T, Free T, E2, CBC, CMP. More frequent monitoring is needed if dose adjustments are being made.
• Annually once stable -- Full panel including PSA, lipid panel, and metabolic markers in addition to hormone levels and CBC.

Key Markers and Target Ranges

Hematocrit is the single most important safety parameter on TRT. Testosterone stimulates erythropoiesis (red blood cell production), which is actually beneficial at moderate levels -- many men report improved energy and exercise capacity as their hematocrit normalizes. However, hematocrit above 52% significantly increases blood viscosity, raising the risk of stroke, deep vein thrombosis, and pulmonary embolism. If your hematocrit rises above 50%, your physician will typically reduce your dose, increase injection frequency (to reduce peaks), or recommend therapeutic phlebotomy (blood donation). If it exceeds 54%, TRT should be temporarily suspended.

Side Effects and Risk Management

Like all medical treatments, TRT carries potential side effects. The good news is that most are dose-dependent, predictable, and manageable with proper monitoring and protocol adjustments. Understanding these risks empowers you to work with your physician to address them proactively rather than reactively.

Polycythemia / Erythrocytosis

The most common side effect of TRT is an increase in red blood cell mass (erythrocytosis), occurring in 5-20% of patients depending on dose and delivery method. Injectable testosterone carries the highest risk due to its peak-trough pharmacokinetics. Management includes dose reduction, splitting the dose into more frequent smaller injections, switching to a gel formulation, or therapeutic phlebotomy (donating blood). Most patients can continue TRT safely with these adjustments.

Estrogen Conversion (Aromatization)

Testosterone is converted to estradiol (E2) by the aromatase enzyme, which is concentrated in adipose (fat) tissue. Men with higher body fat percentages tend to convert more testosterone to estrogen. Elevated estradiol can cause water retention, bloating, mood disturbances, nipple sensitivity, and gynecomastia (breast tissue growth). Target estradiol on TRT is 20-40 pg/mL. If levels consistently exceed 40-50 pg/mL with symptoms, options include lowering the testosterone dose, splitting doses, losing body fat (which reduces aromatase activity), or adding a low-dose aromatase inhibitor (anastrozole 0.25-0.5 mg twice weekly). However, aromatase inhibitors should be used cautiously and only when necessary, as excessively suppressing estradiol impairs bone health, joint function, lipid profiles, and libido.

Acne and Oily Skin

Testosterone stimulates sebaceous gland activity, which can cause acne -- particularly on the back, shoulders, and face. This is more common in the first few months of treatment and in patients with a prior history of acne. Management includes standard dermatological approaches (benzoyl peroxide, salicylic acid, retinoids) and dose optimization. Severe cystic acne may require dose reduction.

Fertility Suppression

Exogenous testosterone suppresses the HPG axis, reducing or eliminating sperm production (spermatogenesis) in the majority of men. This effect is generally reversible upon cessation of TRT, but recovery can take 3-12 months or longer. Men who wish to preserve fertility should discuss HCG co-therapy or alternative treatments (clomiphene, enclomiphene) with their physician before starting TRT. See the TRT and Fertility section below for detailed information.

Testicular Atrophy

Without the stimulation of LH (which is suppressed by exogenous testosterone), the Leydig cells in the testes reduce in size and activity, causing the testes to shrink by approximately 10-25% in volume. This is cosmetic rather than dangerous but can be distressing. Human chorionic gonadotropin (HCG), administered at 250-500 IU two to three times per week alongside TRT, prevents testicular atrophy by mimicking LH at the testicular receptor.

Sleep Apnea

TRT may worsen pre-existing obstructive sleep apnea in some patients, though the data is mixed. A 2023 meta-analysis in Sleep Medicine Reviews found a small but statistically significant increase in apnea-hypopnea index (AHI) scores in men starting TRT. Patients with known sleep apnea or symptoms such as loud snoring, daytime somnolence, or witnessed apneic episodes should undergo a sleep study before and after initiating TRT.

Cardiovascular Risk: What the Evidence Actually Shows

The question of whether TRT increases cardiovascular risk has been one of the most debated topics in endocrinology over the past decade. In 2023, the landmark TRAVERSE trial -- a randomized, double-blind, placebo-controlled study of 5,246 men aged 45-80 with hypogonadism and pre-existing or high risk of cardiovascular disease -- provided the most definitive answer to date. Published in the New England Journal of Medicine, TRAVERSE found no increased incidence of major adverse cardiovascular events (MACE) in the testosterone group compared to placebo over a mean follow-up of 33 months. The hazard ratio was 0.96 (95% CI: 0.78-1.17), effectively ruling out a clinically meaningful cardiovascular risk from TRT when properly prescribed and monitored.

The Endocrine Society's 2018 guidelines and the AUA's 2018 guidelines both state that TRT is not contraindicated in men with controlled cardiovascular risk factors, provided that hematocrit is monitored and maintained below 54%. Men with uncontrolled heart failure (NYHA Class III-IV), recent myocardial infarction (within 6 months), or untreated severe sleep apnea should defer TRT until these conditions are stabilized.

TRT and Fertility

One of the most important conversations to have before starting TRT is about fertility. Exogenous testosterone acts as a male contraceptive -- it suppresses the pituitary gland's production of LH and FSH, which are required for spermatogenesis (sperm production) in the testes. Within 3-6 months of starting TRT, sperm counts drop to zero (azoospermia) in approximately 65% of men, and to severely oligospermic levels (below 1 million/mL) in most of the remainder.

This effect is generally reversible, but recovery is not guaranteed and takes time. After discontinuing TRT, most men recover sperm production within 6-12 months, with some requiring up to 24 months. A small percentage (estimated at 5-10%) may experience prolonged or permanent impairment, particularly after years of uninterrupted TRT use.

Fertility-Preserving Options

• HCG co-therapy (250-500 IU, 2-3 times per week) -- Human chorionic gonadotropin mimics LH at the testicular receptor, maintaining intratesticular testosterone production and preserving spermatogenesis in most men. This is the most common approach for men on TRT who want to maintain fertility. HCG also prevents testicular atrophy.
• Clomiphene citrate (25-50 mg daily or every other day) -- A selective estrogen receptor modulator (SERM) that blocks estrogen feedback at the hypothalamus and pituitary, increasing LH and FSH secretion and stimulating the testes to produce more testosterone endogenously. This raises testosterone levels modestly (typically to 400-600 ng/dL) while preserving or improving sperm production. Clomiphene is used off-label for male hypogonadism and is an alternative to exogenous testosterone for men prioritizing fertility.
• Enclomiphene citrate -- The trans-isomer of clomiphene, enclomiphene has a shorter half-life and fewer estrogenic side effects than clomiphene. It has shown promising results in clinical trials for raising testosterone while maintaining spermatogenesis, though it remains investigational in many markets as of 2026.
• Sperm banking (cryopreservation) -- For men who want the certainty of preserved fertility regardless of their TRT protocol, banking sperm before starting treatment provides a safety net. Cost is typically $500-1,000 for initial collection and $200-400 per year for storage.

Cost Breakdown

The total cost of TRT depends on your delivery method, insurance coverage, pharmacy choice, and monitoring frequency. Below is a realistic breakdown of 2026 pricing to help you budget for treatment. Note that compounded medications from specialty pharmacies often cost significantly less than brand-name products, while offering equivalent efficacy.

Testosterone Products Available at Hormone Pharma

All medications below are FDA-approved, dispensed from licensed U.S. pharmacies, and require a valid prescription from a licensed physician. Start with a consultation to determine which product is right for you.